MIS-C After COVID: Understanding the Syndrome in Children

In this episode of Kid’s Corner, Dr. Liz Mumper discusses MIS-C (Multisystem Inflammatory Syndrome in Children) in the United States and the incidence of this diagnosis with COVID-19. Dr. Mumper also explains if receiving COVID-19 vaccinations prevent MIS-C by breaking down this study.

People also refer to MIS-C as Pediatric Inflammatory Multisystem Syndrome temporally associated with SARS-COV2 (PIM-TS).

Common symptoms of MIS-C in babies show as a rash and/or diarrhea. In older children, the symptoms are respiratory.

MIS-C is similar to Kawasaki’s disease, although the symptoms usually resolve in contrast to Kawasaki’s disease.

Treatment for MIS-C includes:

• supportive care and observation
• maintaining volume status as dehydration worsens symptoms
• steroids
• IVIG
• Interleukin blockers
• anti-coagulation
• cardiology work-up with an EKG and cardiac echo